WASHINGTON, D.C. — April 14, 2011 — Wellmune WGP® reduces allergy symptoms and improves the quality of life of individuals who suffer from ragweed allergy, according to a new clinical study presented yesterday at Experimental Biology 2011, an annual meeting attracting nearly 13,000 scientists and exhibitors.
Ragweed is a leading cause of seasonal allergy symptoms and affects 36 million Americans. Typical symptoms include nasal congestion, sneezing, itchy eyes and difficulty breathing. The cause is an immune system overreaction to ragweed pollen.
The placebo-controlled, double-blinded study of 48 healthy people subjected to high pollen counts last fall. Individuals consuming Wellmune WGP, a natural immune health ingredient from Biothera, demonstrated statistically significant (p<0.05):
• Reductions in overall allergy symptoms and severity.
• Reductions in key nasal and eye-related allergy symptoms.
• Improvement on the Quality of Life Index, a scientifically validated tool for measuring how participants rate their overall sense of wellness.
“Wellmune provided significant relief to study subjects who suffer from the symptoms of ragweed allergies,” said Shawn Talbott, Ph.D., research director at SupplementWatch and lead investigator on the study. [...]